Articles published by Ray Therapeutics

Ray Therapeutics Appoints Scott Braunstein, M.D., as Chairman of the Board of Directors

January 08, 2026

From Ray Therapeutics

Via Business Wire

Ray Therapeutics Awarded $8M CIRM Grant to Advance RTx-015 Gene Therapy for Retinitis Pigmentosa

April 24, 2025

From Ray Therapeutics

Via Business Wire

Ray Therapeutics Appoints Christopher Whitmore as Chief Financial Officer

September 16, 2024

From Ray Therapeutics

Via Business Wire

Ray Therapeutics Receives $4M in Funding from The California Institute for Regenerative Medicine (CIRM)

November 13, 2023

From Ray Therapeutics

Via Business Wire

Ray Therapeutics Announces Promotion of Jenny Holt to Chief Development Officer

August 21, 2023

From Ray Therapeutics

Via Business Wire

Ray Therapeutics Closes Oversubscribed $100M Series A Financing to Advance Optogenetic Gene Therapies for Blinding Diseases

May 16, 2023

From Ray Therapeutics

Via Business Wire

Ray Therapeutics to Present at Upcoming Scientific Conferences

April 11, 2023

From Ray Therapeutics

Via Business Wire

Ray Therapeutics Appoints Dr. Peter Francis as Chief Scientific & Medical Officer and Jenny Holt as SVP, Program Portfolio Management

September 06, 2022

From Ray Therapeutics

Via Business Wire

Ray Therapeutics Receives $4M in Funding From the California Institute for Regenerative Medicine (CIRM)

April 26, 2022

From Ray Therapeutics

Via Business Wire

Ray Therapeutics Closes $6M Seed Financing to Advance Novel Optogenetics Platform to Treat Blinding Diseases

January 04, 2022

From Ray Therapeutics

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.